KD Logo

A company insider recently sold 1,000 shares of Enliven Therapeutics Inc [ELVN]. Should You Sale?

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Enliven Therapeutics Inc shares valued at $25,039 were sold by Hohl Benjamin on Jan 03 ’25. At $25.04 per share, Hohl Benjamin sold 1,000 shares. The insider’s holdings dropped to 13,000 shares worth approximately $0.31 million following the completion of this transaction.

Also, Patel Anish purchased 28,367 shares, netting a total of over 682,794 in proceeds.

Before that, Hohl Benjamin had added 1,000 shares to its account. In a trade valued at $23,900, the Officer bought Enliven Therapeutics Inc shares for $23.90 each.

As published in their initiating research note from BTIG Research on December 13, 2024, Enliven Therapeutics Inc [ELVN] has been a Buy and the price target has been revised to $42. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of June 11, 2024, Robert W. Baird has initiated its “an Outperform” rating for ELVN. Earlier on April 09, 2024, Mizuho initiated its rating. Their recommendation was “a Buy” for ELVN stock.

Analyzing ELVN Stock Performance

During the last five days, there has been a surge of approximately 7.33%. Over the course of the year, Enliven Therapeutics Inc shares have jumped approximately 7.33%. Shares of the company reached a 52-week high of $25.37 on 01/03/25 and a 52-week low of $21.71 on 01/08/25. A 50-day SMA is recorded $25.02, while a 200-day SMA reached $23.30. Nevertheless, trading volume fell to 0.14 million shares from 0.19 million shares the previous day.

Support And Resistance Levels for Enliven Therapeutics Inc (ELVN)

According to the 24-hour chart, there is a support level at 22.50, which, if violated, would cause prices to drop to 20.85. In the upper region, resistance lies at 25.02. The next price resistance is at 25.88. RSI (Relative Strength Index) is 52.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.83, which suggests the price will decrease in the coming days. Percent R is at 30.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular